110 related articles for article (PubMed ID: 3514494)
21. Captopril in the treatment of hypertension associated with claudication.
Libretti A; Catalano M
Postgrad Med J; 1986; 62 Suppl 1():34-7. PubMed ID: 3534862
[TBL] [Abstract][Full Text] [Related]
22. Registry of prospective clinical trials--fifth report.
Verstraete M
Thromb Haemost; 1982 Dec; 48(3):334-8. PubMed ID: 6761891
[No Abstract] [Full Text] [Related]
23. Pathogenesis and prevention of aortocoronary bypass graft occlusion.
Chesebro JH; Fuster V
Int J Clin Pharmacol Res; 1986; 6(4):261-7. PubMed ID: 3531036
[TBL] [Abstract][Full Text] [Related]
24. Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy.
Donadio JV; Anderson CF; Mitchell JC; Holley KE; Ilstrup DM; Fuster V; Chesebro JH
N Engl J Med; 1984 May; 310(22):1421-6. PubMed ID: 6371535
[TBL] [Abstract][Full Text] [Related]
25. [The A.I.C.L.A. controlled cooperative trial. Secondary prevention of cerebral ischemic accidents due to atherosclerosis by aspirin and dipyridamole. 3: Results].
Bousser MG; Eschwege E; Haguenau M; Lefauconnier JM; Thibult N; Touboul D; Touboul PJ
Rev Neurol (Paris); 1983; 139(5):335-48. PubMed ID: 6351216
[TBL] [Abstract][Full Text] [Related]
26. [Naftidrofuryl in the therapy of chronic arterial occlusive disease in the intermittent claudication stage].
Valentin A; Karnik R; Stöllberger C; Slany J
Vasa Suppl; 1987; 20():361-4. PubMed ID: 3321493
[No Abstract] [Full Text] [Related]
27. Treatment of intermittent claudication with antiplatelet agents.
Giansante C; Calabrese S; Fisicaro M; Fiotti N; Mitri E
J Int Med Res; 1990; 18(5):400-7. PubMed ID: 2147914
[TBL] [Abstract][Full Text] [Related]
28. [Training by walking and drug therapy of peripheral arterial occlusive disease].
Kiesewetter H; Blume J; Jung F; Gerhards M; Leipnitz G
Vasa Suppl; 1987; 20():384-7. PubMed ID: 3321495
[No Abstract] [Full Text] [Related]
29. [Intermittent intra-arterial infusion treatment of severe intermittent claudication--results of a prospective double-blind study of prostaglandin E1 versus energy-rich phosphates].
Creutzig A; Caspary L; Radeke U; Specht S; Alexander K
Vasa Suppl; 1988; 23():133-5. PubMed ID: 3061036
[No Abstract] [Full Text] [Related]
30. The effects of physical training and flunarizine on walking capacity in intermittent claudication.
Lepäntalo M; Sundberg S; Gordin A
Scand J Rehabil Med; 1984; 16(4):159-62. PubMed ID: 6397852
[TBL] [Abstract][Full Text] [Related]
31. Dipyridamole - is it a bronchodilator?
Ruffin RE; Newhouse MT
Eur J Respir Dis; 1981; 62(2):123-6. PubMed ID: 7016567
[No Abstract] [Full Text] [Related]
32. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
; Leizorovicz A; Becker F
Circulation; 2008 Feb; 117(6):816-22. PubMed ID: 18212283
[TBL] [Abstract][Full Text] [Related]
33. Antiplatelet therapy for the prevention of recurrent stroke and other serious vascular events: a review of the clinical trial data and guidelines.
Hankey GJ
Curr Med Res Opin; 2007 Jun; 23(6):1453-62. PubMed ID: 17559741
[TBL] [Abstract][Full Text] [Related]
34. [Controlled cooperative trial. Secondary prevention of atherosclerosis-related cerebral ischemic accidents by aspirin dipyridamole. 2: Description of subjects at the beginning of the trial].
Bousser MG; Eschwege E; Haguenau M; Lefauconnier JM; Thibult N; Touboul D; Touboul PJ
Rev Neurol (Paris); 1982; 138(1):1-15. PubMed ID: 7048482
[TBL] [Abstract][Full Text] [Related]
35. [Prevention of re-occlusion after recanalisation of occluded arteries by the catheter method (author's transl)].
Hess H; Müller-Fassbender H; Ingrisch H; Mietaschk A
Dtsch Med Wochenschr; 1978 Dec; 103(50):1994-7. PubMed ID: 720236
[TBL] [Abstract][Full Text] [Related]
36. [Chronic treatment of vascular diseases with indobufen].
Belcaro G; Errichi BM; Laurora G; Marinucci R; Cesarone MR; De Cenzo A
Minerva Cardioangiol; 1989 May; 37(5):241-50. PubMed ID: 2779803
[TBL] [Abstract][Full Text] [Related]
37. [Intermittent intra-arterial infusion treatment of severe intermittent claudication. Results of a prospective double-blind study: prostaglandin El versus energy-rich phosphates].
Creutzig A; Caspary L; Radeke U; Specht S; Ranke C; Alexander K
Med Klin (Munich); 1988 Jun; 83(13-14):434-8. PubMed ID: 3062344
[No Abstract] [Full Text] [Related]
38. Treatment of necrobiosis lipoidica with low-dose acetylsalicylic acid. A randomized double-blind trial.
Beck HI; Bjerring P; Rasmussen I; Zachariae H; Stenbjerg S
Acta Derm Venereol; 1985; 65(3):230-4. PubMed ID: 2411079
[TBL] [Abstract][Full Text] [Related]
39. Physical training and antiplatelet treatment in stage II peripheral arterial occlusive disease: alone or combined?
Mannarino E; Pasqualini L; Innocente S; Scricciolo V; Rignanese A; Ciuffetti G
Angiology; 1991 Jul; 42(7):513-21. PubMed ID: 1863010
[TBL] [Abstract][Full Text] [Related]
40. Prevention of deep venous thrombosis and thrombo-embolism by dipyridamole and acetylsalicylic acid after reconstructive arterial surgery.
Harjola P; Meurala H; Frick MH
J Cardiovasc Surg (Torino); 1980; 21(4):451-4. PubMed ID: 7419561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
